Rocket Lab Onboarded to U.S. Space Force’s $981M NITE-STAR Program to Advance Space Test and Training Infrastructure
Rocket Lab Corporation Rocket Lab Launch Rocket Lab Onboarded to U.S. Space Force’s $981M NITE-STAR Program to Advance…
Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services
Rocket Lab Corporation Rocket Lab Lightning Bus Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit,…
Rocket Lab Establishes Rocket Lab Germany to Deliver Sovereign Space Capabilities to Europe
Rocket Lab Corporation MUNICH, Aug. 10, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a global leader…
Rocket Lab Delivers Mission Success for Space Force: Completes Historic Launch and On-Orbit Satellite Tracking Mission in Record Time
Rocket Lab Corporation Following a record-shattering responsive launch, Rocket Lab completes complex on-orbit rendezvous and proximity operations, proving…
Cycurion, Inc. Completes Transformative Acquisition of Secuvant, LLC and Flagship Panoptic Cybersecurity Platform
MCLEAN, Va., June 09, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading…
Mission Success: Rocket Lab Completes 9th Electron Launch for Synspective
Rocket Lab Corporation MAHIA, New Zealand, May 22, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a…
Rocket Lab and Raytheon Selected To Demonstrate Advanced Capabilities For U.S. Space Force’s Space Based Interceptor Program
Rocket Lab Corporation LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a…
AST SpaceMobile Addresses Today’s Orbital Launch of BlueBird 7 on the New Glenn Launch Vehicle
MIDLAND, Texas, April 19, 2026–(BUSINESS WIRE)–AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and…
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Praxis Precision Medicines, Inc. FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026…
Palladyne AI Subsidiary Selected by U.S. Navy to Develop Low Cost Near Hypersonic Missile
SALT LAKE CITY, March 18, 2026–(BUSINESS WIRE)–Palladyne AI Corp. (Nasdaq: PDYN and PDYNW) subsidiary, GuideTech (“Palladyne AI”) has…
Rocket Lab Secures Latest Multi-Launch Contract with BlackSky for 4x Dedicated Electron Missions
Rocket Lab Corporation LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Rocket Lab USA, Inc. (Nasdaq: RKLB)…
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…